“PLASMA FIBRINOGEN: A CARDIOVASCULAR RISK BIOMARKER IN TYPE 2 DIABETES MELLITUS SUBJECTS: Plasma fibrinogen”, FJS, vol. 6, no. 3, pp. 100–104, Jun. 2022, doi: 10.33003/fjs-2022-0603-915.